Concepedia

Phase II study of high-dose epirubicin in non-small cell lung cancer

J. Wils, I Made Susila Utama, Luca Sala, J. Smeets, Agostino Riva

European Journal of Cancer and Clinical Oncology · 1990 · 35 citations · 4 references

Concepts

MedicineOncologyPharmacologyCancer PharmacologyChemotherapyPharmacokinetics Of Anticancer AgentsLung CancerLung Cancer PharmacotherapyMalignant NeoplasmsPharmacodynamics Of Anticancer AgentsPharmacodynamics Of Anticancer DrugsPharmacokinetics Of Anticancer DrugsAnthracycline-based ChemotherapyNon-small Cell Lung Cancer TherapyNon-small Cell Lung Cancer TreatmentPhase Ii InvestigationStudy Phase

References

4

A randomized study comparing a high and a standard dose of cisplatin in combination with etoposide in the treatment of advanced non-small-cell lung carcinoma.

Jean Klášterský, Jean‐Paul Sculier, P Ravez et al. · Journal of Clinical Oncology · 1986 · 136 citations

Medicine, Oncology, Pharmacology +15

Cisplatin versus cisplatin plus etoposide in the treatment of advanced non-small-cell lung cancer. Lung Cancer Working Party, Belgium.

Jean Klášterský, Jean‐Paul Sculier, G. Bureau et al. · Journal of Clinical Oncology · 1989 · 131 citations

Medicine, Oncology, Pharmacology +14

Chemotherapy Consisting of Epirubicin, Cisplatin, and Etoposide Followed by Irradiation in Stage III Non-Small Cell Lung Cancer and Chemotherapy Alone in Stage IV Non-Small Cell Lung Cancer

J.W. Wils, I Made Susila Utama, J. Smeets · Oncology · 2009 · 10 citations

Medicine, Oncology, Radiation Oncology +8

Good clinical practice: a way to better drugs.

E Hvidberg · BMJ · 1989 · 10 citations · Full text

Health Professions, Internal Medicine, Clinical Medicine +9